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AT1a receptor knockout in mice impairs urine
concentration by reducing basal vasopressin
levels and its receptor signaling proteins in
the inner medulla
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Angiotensin II plays an important role in the regulation of blood
pressure, body salt and fluid balance, and urine concentration.
Mice with deletion of the AT1a receptor develop polyuria and
urine concentration defects. We studied the mechanisms of
these urine concentration defects by treating wild-type and
AT1a-knockout mice with arginine vasopressin (AVP) for 2
weeks, controlling their water intake, or giving them an osmotic
diuretic (sucrose) in order to determine whether central or
nephrogenic mechanisms were involved. Under basal
conditions, AT1a-knockout mice were hypotensive, had lower
plasma AVP, and excreted more urine with a markedly reduced
osmolality compared with wild-type mice. However, basal
glomerular filtration rates were similar in both strains of mice.
We isolated total lysate and membrane proteins from the inner
medulla of wild-type and mutant mouse kidneys, and found
that the amounts of aquaporin 2 (AQP2), adenylyl cyclases III
and V/VI, and phosphorylated MAP kinases ERK 1/2 proteins
were all reduced in the inner medulla of the knockout mice.
Infusion of AVP raised plasma levels and blood pressure
proportionally in both strains, but polyuria persisted and
urine osmolality remained significantly lower in the knockout
mice. Although AVP increased urine osmolality slightly in
water-deprived knockout mice, this was well below the basal
osmolality of wild-type mice. The diuretic response to the
hyperosmotic sucrose was also impaired in the knockout mice.
Neither AVP nor water rationing restored the levels of the inner
medullary signaling proteins and membrane AQP2 proteins
in the knockout mice. We suggest that AT1a receptor deletion
causes polyuria and urine concentration defects by decreasing
basal AVP release and impairing AVP-induced receptor signaling
in the inner medulla.
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An important role of angiotensin II (Ang II) in the
physiological regulation of blood pressure, body salt and
fluid balance, and urine concentration is now well-recognized
in mice with genetic deletion of one of the major compo-
nents of the renin–angiotensin system. Elimination of genes
encoding renin, angiotensinogen,1,2 angiotensin I-converting
enzyme, which coverts Ang I to biologically active Ang II,3 or
entire AT1 receptors
4 leads to the development of hypo-
tension, structural abnormalities in the renal papilla, and
polyuria with reduced urine osmolality. Structural defects in
the papilla of the inner medulla (IM) are thought to be the
major contributing factors to polyuria and reduced urine
osmolality in these animals.1,3,4 Surprisingly, the deletion of
AT1a receptors alone in mice did not result in structural
abnormalities in the renal papilla.5,6 Yet AT1a-knockout (KO)
mice still excrete two to fourfold more urine with a sig-
nificantly reduced osmolality than wild-type (WT) mice.5,6
These abnormal phenotypes strongly suggest functional,
rather than structural, defects in urine concentrating mecha-
nisms in AT1a-KO mice.
Although polyuria with reduced urine osmolality has
been reported in AT1a-KO mice, the mechanisms responsible
for these defects have not been investigated earlier. Urine
concentration in the IM of the kidney, collecting ducts by
implication, is regulated by both central and renal mecha-
nisms; namely (1) release of arginine vasopressin ([Arg8]-
AVP) from the hypothalamic neurohypophyseal tract;7
(2) water intake regulated by central thirst mechanisms;8
(3) integrity of inner medullary structures; (4) expression of
type 2 receptors (V2) in collecting ducts;
9 and (5) responses
of collecting ducts to AVP-activated V2 receptor signal-
ing.10,11 Ang II, through the activation of AT1a and AT1b
receptor signaling, plays an important role in regulating
AVP release from the hypothalamic neurohypophyseal tract
and cross-talks with V2 receptor signaling in the collecting
ducts.7,8,12 Thus, the development of polyuria with markedly
reduced urine osmolality in AT1a-KO mice may be because of
central defects in AVP release (central diabetes insipidus),
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thirst mechanisms (primary polydipsia), or to renal tubu-
lar defects in concentrating urine (nephrogenic diabetes
insipidus).
This study tested the hypothesis that the development of
polyuria and urine concentration defects in AT1a-KO mice
is due to the deletion of the AT1a receptors and their
signaling transductions that regulate basal [Arg8]-AVP release
and V2 receptor signaling (A-cyclase (AC)-III and AC-V/VI),
and the expression of membrane aquaporin 2 (AQP2) pro-
teins in the IM of the kidney.
RESULTS
Systemic and renal responses to [Arg8]-AVP infusion
or 24-h water ration in WT and AT1a-KO mice
Table 1 shows that basal systolic pressure and plasma [Arg8]-
AVP were significantly lower in AT1a-KO than in WT mice
(Po0.01). Infusion of [Arg8]-AVP for 2 weeks increased the
systolic pressure proportionally in both strains (Po0.01 vs
controls). Plasma [Arg8]-AVP levels were also increased
similarly by [Arg8]-AVP infusion in both strains (Po0.01 vs
controls). 24-h water ration did not alter plasma [Arg8]-AVP
in WT, but it increased plasma AVP levels in AT1a-KO mice
(Po0.01). Under the same condition that all mice had free
access to water, basal 24-h water intake and urine excretion
was 43 times higher in AT1a-KO than in WT mice (Po0.01).
[Arg8]-AVP infusion reduced 24-h urine and sodium excre-
tion in both strains (Po0.01), but it did not restore these
responses in AT1a-KO mice compared with those of WT mice.
24-h water ration failed to restore 24-h urine and electrolyte
responses in AT1a-KO mice to the levels of WT mice.
Basal glomerular filtration rate and inner medullary
structures of WT and AT1a-KO mice
Basal glomerular filtration rates (GFR), as determined by the
fluorescein isothiocyanate-inulin clearance technique,13 were
not significantly different in conscious age and body weight-
matched male WT and AT1a-KO mice (Table 2). There were
also no striking differences in inner medullary structures
between WT and AT1a-KO mice at low-power microscopic
visualization (Figure 1). No papillary malformation, atrophy
or fibrosis was observed in AT1a-KO mice. Total inner
medullary proteins, as normalized to their kidney weights,
were comparable between WT and AT1a-KO mice (Table 2).
Effects of [Arg8]-AVP infusion or 24-h water ration on
plasma and urine osmolality
Basal plasma osmolality was not statistically different (WT:
323±11 vs AT1a-KO: 315±7 mOsm per kg H2O; NS)
(Figure 2). However, urine osmolality was markedly reduced
in AT1a-KO mice (WT: 2227±95 vs AT1a-KO: 1004±137
mOsm per kg H2O; Po0.01). In response to [Arg8]-AVP
infusion for 2 weeks, WT mice maintained plasma osmolality
at the control level (326±14 mOsm per kg H2O, NS). By
contrast, plasma osmolality was decreased in AT1a-KO mice
(288±12 mOsm per kg H2O; Po0.01 vs controls) (Figure 2).
Although urine osmolality was increased by [Arg8]-AVP
infusion in both strains, it remained remarkably reduced in
AT1a-KO mice (WT: 3937±268 vs AT1a-KO: 1893±349
mOsm per kg H2O; Po0.01) (Figure 2). 24-h water
ration increased plasma osmolality in AT1a-KO mice
(338±10 mOsm per kg H2O, Po0.05 vs controls), but it
did not restore urine osmolality to the WT level (WT:
2044±86 vs AT1a-KO: 948±148 mOsm per kg H2O,
Po0.01).
Table 1 | Basal 24-h water intake and renal excretory indexes and their responses to 2-week [Arg8]-AVP infusion or 24-h water
ration in wild-type (WT) and AT1a-KO mice
WT AT1a-KO
Parameters Control [Arg8]-AVP 24-h water ration Control [Arg8]-AVP 24-h water ration
Body wt. (g) 23.8±0.5 21.4±0.5 23.5±1.0 24.7±0.9 22.4±0.4 22.2±1.0
SBP (mm Hg) 122±6 149±5** 118±8 94±5 123±8**ww 90±6ww
Plasma AVP (pmol/l) 115.3±18.4 215.8±36.2** 113.7±11.6 38.1±12.9## 129.1±12.8**ww 81.2±11.9**ww
Kidney wt. (g) 0.35±0.03 0.34±0.02 0.34±0.02 0.27±0.02## 0.27±0.02ww 0.26±0.02ww
Kidney to body wt. ratio ( 100) 1.26±0.06 1.49±0.04** 1.31±0.03 1.13±0.06# 1.20±0.08ww 1.17±0.07ww
Water intake (ml/24 h) 3.8±0.2 2.8±0.2** 4.0±0.2 10.7±1.3## 6.5±0.8*ww 4.0±0.2
Urine output (ml/24 h) 1.51±0.10 0.62±0.08** 1.56±0.11 5.33±0.73## 1.93±0.64**w 3.58±0.45ww
UNaV (mmol/24 h) 224.4±6.3 170.7±8.6* 208.3±10.5 273.9±6.5
# 102.8±7.0**w 151.6±18.2w
UKV (mmol/24 h) 491.6±13.3 387.8±18.3 466.2±20.3 506.2±9.6 210.1±14.2**
ww 367.5±21.3w
[Arg8]-AVP, arginine vasopressin; KO, knockout; SBP, systolic blood pressure; UNaV, urinary sodium excretion; UKV, urinary potassium excretion; wt., weight.
Values are means±s.e.
*Po0.05 or **Po0.01 vs their WT or AT1a-KO controls. #Po0.05 or ##Po0.01 vs WT controls.
wPo0.05 or wwPo0.01 vs the corresponding group of WT mice treated with [Arg8]-AVP or with 24-h water ration.
Table 2 | Basal glomerular filtration rate (GFR), total kidney
weights and inner medullary proteins, and the inner-
medullary-protein-to-kidney-weight ratio in age and body
weight–matched male wild-type (WT) and AT1a-KO mice
Parameter WT AT1a-KO
GFR (ml/min) 134.9±40.9 130.6±17.2
Total kidney wt. (mg) 350±20 270±25*
Total inner medullar proteins (mg) 12.6±0.5 9.9±0.4*
Inner medulla protein/kidney wt. ratio, ( 100) 3.6±0.3 3.7±0.5
FITC, fluorescein isothiocyanate; GFR, Glomerular filtration rate, KO, knockout;
wt., weight.
Glomerular filtration rate was determined in conscious wild-type and AT1a-KO mice
using the FITC-labeled inulin method.13
*Po0.05 vs wild-type mice, unpaired t-test.
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Urine osmolality responses to acute [Arg8]-AVP
administration in water-deprived WT and AT1a-KO mice
Water deprivation (WD) for 16 h significantly reduced urine
excretion in both WT (basal: 1.4±0.2 ml vs WD: 0.6±0.1 ml,
Po0.01) and AT1a-KO mice (basal: 4.8±0.8 ml vs WD:
2.1±0.3 ml, Po0.01). Figure 3 shows that urine osmolality
was markedly increased in WT (basal: 1767±183 mOsm
per kg H2O vs WD: 3049±275 mOsm per kg H2O, Po0.01),
but not in AT1a-KO mice (basal: 976±71 mOsm per kg
H2O vs WD: 1195±101 mOsm per kg H2O, NS). Sub-
sequent administration of [Arg8]-AVP did not significantly
increase urine osmolality in WT mice (AVP: 3539±309
mOsm per kg H2O, NS vs WD). Although [Arg
8]-AVP
induced a 16% increase in urine osmolality in water-deprived
AT1a-KO mice (AVP: 1391±168 mOsm per kg H2O), the
increase was not statistically different from that induced by
WD. However, AVP did increase the urine osmolality signif-
icantly above the basal level in AT1a-KO mice (Figure 3).
[125I]-V2 receptor binding in the IM
[125I]-V2 receptor binding in the IM was increased in the
IM of AT1a-KO mice (WT: 139±8 dpm/mm
2 vs AT1a-KO:
170±6 dpm/mm2; Po0.05) (Figure 4). Infusion of [Arg8]-
AVP for 2 weeks decreased V2 receptor binding similarly in
the IM of WT and AT1a-KO mice (WT: 88±7 vs AT1a-KO:
72±6 dpm/mm2, NS) (Figure 4).
Figure 1 | Anatomical and low-power microscopic
visualization of cortical and inner medullary structures
of WT and AT1a-knockout (KO) mice. (a) A representative
midline cross section of a WT kidney. (b) A representative
midline cross section of an AT1a-KO kidney. (c) A representative
low-power micrograph of a WT kidney showing the papilla tip of
the inner medulla. (d) A representative low-power micrograph of
an AT1a-KO kidney showing the papilla tip of the inner medulla.
Kidney sections were stained with hematoxylin and eosin. WT,
wild type.
5000
4000
3000
2000
1000
0
++
++
++
+
+
*
**
**
400
350
300
250
200
150
100
Pl
as
m
a 
os
m
ol
al
ity
[m
Os
m 
pe
r k
g H
2O
]
Ur
in
e 
os
m
ol
al
ity
[m
Os
m 
pe
r k
g H
2O
]
WT AT1a-KO
WT AT1a-KO
Control + AVP + 24-h WR
Control + AVP + 24-h WR
Figure 2 | Basal plasma and urine osmolality and their
responses to 2-week infusion of arginine vasopressin
([Arg8]-AVP) or 24-h water ration (WR) in wild-type (WT)
and AT1a-KO mice. *Po0.05 or **Po0.01 vs respective WT
or AT1a-KO controls;
þPo0.05 or þþPo0.01 vs WT controls,
[Arg8]-AVP-treated, or 24-h water-rationed WT mice.
AVP, arginine vasopressin.
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Figure 3 | Urine osmolality responses to acute administration
of arginine vasopressin ([Arg8]-AVP) in water-deprived
wild-type (WT) (n¼ 6) and AT1a-KO mice (n¼ 9). All mice
were water-deprived for 16 h before [Arg8]-AVP was administered
(100 ng per mouse, i.p.). **Po0.01 vs WT basal values. þþPo0.01
vs corresponding WT values. #Po0.05 vs basal values in AT1a-KO
mice. WD, water deprivation.
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Effects of [Arg8]-AVP infusion or 24-h water ration
on lysate and membrane AQP2 proteins in the IM
Under basal conditions, lysate AQP2 proteins in the IM of
AT1a-KO mice were o30% of WT mice (WT: 0.72±0.08 vs
AT1a-KO: 0.21±0.05 AQP2/Actin ratio, Po0.01) (Figure 5).
[Arg8]-AVP significantly increased lysate AQP2 proteins
in both strains (WT: 1.56±0.23 vs AT1a-KO: 1.33±0.16
AQP2/Actin ratio, Po0.01 vs controls). However, 24-h
water ration did not restore lysate AQP2 protein levels in
AT1a-KO mice to those of WT mice (WT: 1.33±0.21 vs
AT1a-KO: 0.82±0.25 AQP2/Actin ratio, Po0.01) (Figure 5).
Figure 6 further shows that [Arg8]-AVP increased inner
medullary membrane AQP2 proteins by B62% in WT mice
(control: 0.53±0.06 vs [Arg8]-AVP: 0.86±0.08 AQP2/Actin
ratio, Po0.01), but by only 10% in AT1a-KO mice (control:
0.18±0.05 vs [Arg8]-AVP: 0.20±0.04 AQP2/Actin ratio, NS).
The 24-h water ration had no significant effect on inner medul-
lary membrane AQP2 proteins in AT1a-KO mice (Figure 6).
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Figure 4 | Specific [125I]-V2 receptor binding in the inner
medulla (IM) of wild-type (WT) and AT1a-KO mice, as
determined by quantitative in vitro autoradiography.
(a) A representative [125I]-V2 receptor autoradiograph in a control
WT kidney. (b) A representative [125I]-V2 receptor autoradiograph
in an AT1a-KO kidney. (c) A representative [
125I]-V2 receptor
autoradiograph in an AVP-infused WT kidney. (d) A representative
[125I]-V2 receptor autoradiograph in an AVP-infused AT1a-KO
kidney. **Po0.01 vs their respective WT or AT1a-KO mice controls.þþPo0.01 vs WT controls. AVP, arginine vasopressin.
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Figure 5 | Semiquantitative immunoblots of lysate aquaporin
2 (AQP2) proteins in wild-type (WT) and AT1a-KO mice
under basal conditions or after 2-week infusion of arginine
vasopressin ([Arg8]-AVP) or 24-h water ration (WR).
Immunoblots of actin in the same membrane was used as an
index of equal loading. **Po0.01 vs respective WT or AT1a-KO
controls; þþPo0.01 vs WT controls.
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Figure 6 | Semiquantitative immunoblots of membrane
aquaporin 2 (AQP2) proteins in wild-type (WT) and AT1a-KO
mice under basal conditions or after 2-week infusion of
arginine vasopressin ([Arg8]-AVP) or 24-h water ration (WR).
**Po0.01 vs respective WT or AT1a-KO controls; þþPo0.01 vs WT
controls or WT mice treated with [Arg8]-AVP or 24-h water ration.
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Effects of [Arg8]-AVP infusion or 24-h water ration
on AC-III and AC-V/IV proteins in the IM
Basal AC-III proteins were 61% lower in AT1a-KO than in the
WT mice (WT: 0.46±0.08 vs 0.18±0.06 AC-III/Actin ratio,
Po0.01) (Figure 7). [Arg8]-AVP increased AC-III proteins
by 60% in WT mice (AVP: 0.82±0.10 AC-III/Actin ratio;
Po0.01 vs control), but had no effect on the AC-III proteins
in AT1a-KO mice (AVP: 0.26±0.08 AC-III/Actin ratio; NS vs
control). 24-h water ration failed to increase AC-III proteins
in AT1a-KO mice to the WT level (WT; 0.72±0.08 vs AT1a-
KO: 0.22±0.08 AC-III/Actin ratio, Po0.01). Figure 8 further
shows that basal AC-V/VI proteins were threefold higher in
the IM of WT than in the AT1a-KO kidneys (WT: 0.53±0.06
vs AT1a-KO: 0.16±0.03 AC V/VI/Actin ratio, Po0.01).
Again, [Arg8]-AVP or 24-h water ration did not restore AC-
V/VI protein expression in AT1a-KO mice to the level of WT
mice (WT: 0.56±0.08 vs AT1a-KO: 0.20±0.08 AC-V/VI/
Actin ratio, Po0.01) (Figure 8).
Effects of [Arg8]-AVP infusion or 24-h water ration
on activation of MAP kinases ERK 1/2 in the IM
Basal level of phosphorylated extracellular signal-regulated
kinase (p-ERK) 1/2 proteins in the IM was 80% lower in
AT1a-KO than in WT mice (Figure 9). [Arg
8]-AVP increased
p-ERK 1/2 proteins by 89% in WT mice (control: 0.89±0.10
vs [Arg8]-AVP: 1.68±0.23 p-ERK/t-ERK (total ERK) 1/2
ratio; Po0.01), but it had no effect on the p-ERK 1/2
proteins in AT1a-KO mice (control: 0.18±0.08 vs [Arg
8]-
AVP: 0.25±0.06 p-ERK/t-ERK 1/2 ratio; NS). 24-h water
ration did not increase the levels of p-ERK 1/2 in the IM
of AT1a-KO mice (WT: 1.06±0.12 vs AT1a-KO: 0.33±0.08
p-ERK/t-ERK 1/2 ratio; Po0.01).
Effects of 5-day water ration on 24-h urine excretion,
urine osmolality, and inner medullary lysate and
membrane AQP2 proteins
Similar to the responses to 24-h water ration in AT1a-KO
mice, the 5-day water ration protocol also failed to restore
24-h urine excretion, urine osmolality, and inner medullary
lysate and membrane AQP2 and AC-III proteins to the levels
of WT mice (Figure 10).
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Figure 7 | Semiquantitative immunoblots of A-cyclase-III
proteins in wild-type (WT) and AT1a-KO mice under
basal conditions or after 2-week infusion of arginine
vasopressin ([Arg8]-AVP) or 24-h water ration (WR).
**Po0.01 vs WT controls; þþPo0.01 vs respective WT controls,
or WT mice treated with [Arg8]-AVP or 24-h water ration.
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Figure 8 | Semiquantitative immunoblots of A-cyclase-V/VI
proteins in wild-type (WT) and AT1a-KO mice under basal
conditions or after 2-week infusion of arginine vasopressin
([Arg8]-AVP) or 24-h water ration (WR). þþPo0.01 vs WT mice
treated with [Arg8]-AVP or with 24-h water ration.
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Figure 9 | Semiquantitative immunoblots of phosphorylated
MAP kinases ERK 1/2 proteins (p-ERK 1/2) in wild-type (WT)
and AT1a-KO mice under basal conditions or after 2-week
infusion of arginine vasopressin ([Arg8]-AVP) or 24-h water
ration (WR). **Po0.01 vs WT controls; þþPo0.01 vs respective
WT controls or WT mice treated with [Arg8]-AVP or 24-h water
ration. t-ERK, total extracellular signal-regulated kinase.
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Effects of 24-h treatment with 10% sucrose on urine
excretion, plasma and urine osmolality, inner medullary
AQP2 and AC-III protein expression
Although WT and AT1a-KO mice drank similar amounts
of sucrose solution (13.1 vs 14.1 ml/24 h; NS), the osmotic
agent induced a greater osmotic diuresis in WT mice than
in AT1a-KO mice (Figure 11). 24-h urine excretion was
increased by fivefolds in WT mice (1.3±0.3 vs 6.5±1.3 ml/
24 h, Po0.01), but by only by onefold in AT1a-KO mice
(4.5±0.3 vs 8.1±1.0 ml/24 h, Po0.01) (Figure 11a). Plasma
osmolality was not significantly altered in WT (323±3
vs 317±4 mOsm per kg H2O, NS) or in AT1a-KO mice
(324±3 vs 318±3 mOsm per kg H2O, NS). Urine osmolality
was sharply decreased in WT mice from 2379±95 mOsm
per kg H2O to 417±68 mOsm per kg H2O (Po0.01) and
in AT1a-KO mice from 828±71 to 326±31 mOsm per
kg H2O (Po0.01), respectively (Figure 11b). Sucrose treat-
ment increased the inner medullary AQP2 proteins from
0.70±0.05 to 1.72±0.10 AQP2/Actin ratio in WT mice
(Po0.01), but only from 0.23±0.03 to 0.30±0.05 AQP2/
Actin ratio in AT1a-KO mice (Figure 11c). Likewise, AC-III
expression was increased by sucrose in WT mice (0.16±0.03
vs 0.38±0.08 AC-III/Actin ratio, Po0.01), but not in
AT1a-KO mice (0.03±0.02 vs 0.06±0.03 AC-III/Actin ratio,
NS) (Figure 11d). Osmotic responses to 2 week’s sucrose
treatment in WT or AT1a-KO mice were similar to their
24-h treatment, and therefore were not shown here.
DISCUSSION
This study shows that AT1a-KO mice developed polydipsia,
polyuria, and urine concentration defects, which were asso-
ciated with a significantly reduced basal circulating [Arg8]-
AVP levels, urine osmolality, lysate and membrane AQP2
proteins, AC-III, AC-V/VI and phosphorylated mitogen-
activated protein kinase (MAP) kinases ERK 1/2 signaling
proteins in the IM. Our results suggest that central polydipsia
is unlikely the major cause of polyuria and urine concen-
tration defects in AT1a-KO mice, because the same 24-h
or 5-day water ration to restrict excessive drinking in AT1a-
KO mice to the WT levels did not normalize 24-h urine
excretion, urine osmolality, and inner medullary AQP2 and
V2 receptor signaling proteins to the WT levels. Neither
osmotic diuresis because of markedly increased GFR and
solute washout nor inner medullary structural abnormalities
seemed to contribute substantially to the urine concentration
defects in AT1a-KO mice. By contrast, partial [Arg
8]-AVP
deficiency and functional defects in AT1a receptor-regulated
V2 receptor signaling in the IM because of the deletion of AT1a
receptors may have played a critical role in the development
of polyuria and urine concentration defects in these mice.
It is well documented that deletion of angiotensinogen, ACE,
or AT1 receptors (AT1a and AT1b) in mice is associated with a
hypoplastic papilla in the renal medulla and polyuria with
markedly diluted urine.1–4 In this study, we first reasoned
whether AT1a-KO mice developed similar structural abnormali-
ties or atrophy in the IM, which may explain the development of
polyuria and severely diluted urine in these mice. Oliverio et al.6
earlier showed that deletion of AT1a receptors alone in mice
developed polyuria with a reduced urine osmolality. Further
magnetic resonance imaging of renal cortical and medullary
structures of WT and AT1a-KO mice found no apparent struc-
tural differences between these animals.6 Furthermore, deletion
of AT1b receptors alone in mice also does not alter blood pres-
sure and any renal structure or function.14 In this study, we did
not observe apparent structural abnormalities in the papilla of
AT1a-KO mice at low-power and microscopic levels (Figure 1),
or significant differences in inner medullary weights and proteins
relative to their kidney weights (Table 2). These results suggest
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that polyuria and urine concentrating defects in AT1a-KO mice is
unlikely due to structural defects in the IM.
We next investigated whether the development of poly-
uria and urine concentrating defects in AT1a-KO mice may
be caused by central polydipsia or defects in central thirst
mechanisms,8 because AT1a-KO mice drank three-times more
water than WT controls (Table 1).15,16 Central polydipsia is a
compulsive drinking disorder and unrestricted water intake
alone may lead to polyuria and reduce urine osmolality.
However, if central polydipsia is the primary cause, water
restriction and AVP treatment in these mice are expected to
correct polyuria and restore urine osmolality to WT levels.
In this study, both acute 24-h and 5-day water ration failed
to normalize polyuria and urine concentration defects in AT1a-
KO mice. Nevertheless, we recognize that 5 days of controlled
water intake in this study may not be of sufficient duration to
reverse a urine concentrating defect because of lifelong central
polydipsia in AT1a-KO mice. The alternative explanation may be
that AT1a-KO mice have hypotension, which stimulates thirst
leading to polydipsia and reduced urine osmolality. However,
hypotension, polyuria and lower urine osmolality are expected
to stimulate AVP release to correct these defects in these mice.7,8
Thus, central polydipsia or defects in central thirst mechanisms
may not play major roles in the development of polyuria and
urine concentration phenotypes in AT1a-KO mice.
In an attempt to exclude the possibility that polyuria and
urine concentration defects in AT1a-KO mice may result from
an osmotic diuresis due to markedly increased GFR, and
therefore solute and fluid delivery from proximal tubules, we
first measured basal GFR in conscious WT and AT1a-KO mice
using the fluorescein isothiocyanate-inulin clearance method.13
As basal GFR values were comparable in conscious age and
body weight-matched male WT and AT1a-KO mice, increased
filtered load may be excluded as a major con-
tributing factor for polyuria and low urine osmolality in the
latter mice (Table 2). Furthermore, we treated WT and AT1a-
KO mice with the osmotic agent (10% sucrose) acutely for 24 h
or chronically for 2 weeks to induce osmotic diuresis.17 It was
expected that the osmotic agent markedly increases solute and
fluid delivery from proximal tubules, impairs medullary
osmotic equilibrium and interstitial tonicity, and induces
solute washout. As expected, WT mice responded to the
osmotic agent by markedly increasing urine excretion and
maximally decreasing urine osmolality by fivefolds, and
increasing AQP2 and AC-III proteins in the IM (Figure 11).
Similar osmotic diuretic responses occurred with sucrose
treatment for 2 weeks (not shown), and have been shown in
normal and uncontrolled diabetic rats.18,19 However, osmotic
diuretic responses and the decreases in urine osmolality by
sucrose treatment were markedly impaired in AT1a-KO mice.
Osmotic diuresis did not increase the inner medullary AQP2
and AC-III signaling proteins in AT1a-KO mice. These dif-
ferent polyuric responses to an osmotic agent between WT and
AT1a-KO mice suggest that osmotic diuresis also unlikely
contributes to the development of polyuria and urine con-
centration defects in AT1a-KO mice.
[Arg8]-AVP is the major antidiuretic hormone, and its
synthesis and release are physiologically regulated by Ang II
through the AT1a and AT1b receptors in the paraventricular
nucleus and pituitary glands.7,8,20 Genetic deletion of AT1a
receptors may cause partial central diabetes insipidus as a
result of partial [Arg8]-AVP deficiency. In this study, the basal
circulating [Arg8]-AVP levels in AT1a-KO mice were o50%
of WT mice (Table 1), in spite of polyuria and a markedly
reduced urine osmolality (Figure 2). This is in contrast with
earlier studies that reported that serum [Arg8]-AVP levels in
AT1a-KO mice were not different from, lower or higher than,
those of WT mice.6,21,22 Oliverio et al.6 found that serum
[Arg8]-AVP levels tended to be higher in AT1a-KO mice, and
yet these mice still responded to 1-desamino-8-D-arginine
vasopressin, although to a smaller extent. The reasons under-
lying these differences in serum [Arg8]-AVP levels in AT1a-KO
mice are not clear. However, the genotype of AT1a-KO mice
used in this study is unlikely the cause for these differences,
because our mice were bred from the same colony, and all
AT1a-KO mice were confirmed by genotyping before experi-
ment and by [125I]-Ang II autoradiography showing the lack
of AT1 receptor binding in the kidney.
15,16 Instead, the differ-
ences are probably because of the specificity and sensitivity of
radioimmunoassay vs enzyme-linked immunosorbent assay
used, the ways how blood samples were collected and pre-
pared, and the number of blood samples assayed between
studies.6,21,22 Our finding that basal serum [Arg8]-AVP levels
were lower in AT1a-KO mice is not entirely surprising,
because both AT1a and AT1b receptors are expressed in the
paraventricular nucleus and pituitary glands.20–22 Indeed, our
interpretation is also consistent with the observations that
both control or water-deprived AT1a-KO mice still partially
responded to acute or long-term [Arg8]-AVP administration
by attenuating polyuria and/or increasing urine osmolality
above their basal levels, albeit to much less extents than WT
mice (Figures 2 and 3).
However, partial [Arg8]-AVP deficiency (or partial central
diabetes insipidus) cannot fully explain polyuria and urine
concentration defects in AT1a-KO mice. We reasoned that
if [Arg8]-AVP deficiency is the sole factor responsible for
these defects in AT1a-KO mice, replacement of [Arg
8]-AVP
acutely or for 2 weeks would normalize urine excretion,
urine osmolality, and V2 receptor signaling proteins to
those of WT mice. Although a lower basal [Arg8]-AVP
level may partly explain increased basal 24-h urine excre-
tion (Table 1), reduced basal urine osmolality (Figures 2
and 3), and decreased basal lysate (Figure 5) and membrane
AQP-2 (Figure 6), AC-III (Figure 7) and AC-V/VI (Figure 8),
and p-ERK 1/2 proteins (Figure 9) in AT1a-KO mice,
infusion of [Arg8]-AVP for 2 weeks did not completely
normalize polyuria, urine concentrating ability and V2
receptor signaling proteins in the IM of AT1a-KO mice.
The impaired responses to [Arg8]-AVP were also unlikely
due to a decrease in V2 receptor numbers in the IM of
AT1a-KO mice, because specific [
125I]-V2 receptor binding
in the IM was slightly upregulated in AT1a-KO mice
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(Figure 4), probably due to a decrease in basal [Arg8]-AVP
levels (Table 1).23,24
Although [Arg8]-AVP and water ration increased lysate
AQP2 proteins in the IM of AT1a-KO mice, they had no
significant effects on membrane AQP2 proteins, AC-III and
AC-V/VI, or p-ERK 1/2 proteins in the IM of the AT1a-KO
mice. This suggests that the defects in AQP2 trafficking
to the membranes, rather than the defects in AQP2 bio-
synthesis, contribute to the development of polyuria and
urine concentration defects in the AT1a-KO mice. It is well-
recognized that in collecting tubules, [Arg8]-AVP binds V2
receptors and activates AC-III and AC-V/VI, leading to an
increase in intracellular cAMP levels.25,26 cAMP activates
protein kinase A and MAP kinase ERK 1/2, which in turn
induce phosphorylation of AQP2 proteins and its mem-
brane insertion.26–28 V2 receptor-mediated activation of
adenylyl cyclases and cAMP production plays an important
role in the translocation of AQP2 proteins from intracellular
vesicles to apical membranes of principal cells of medullary
collecting ducts.
These results suggest that AT1a receptor signaling is
required for the regulation of V2 receptor-mediated water
transport and urine concentration in the IM. How Ang II
through the AT1a receptors and AVP through the V2 receptors
interact to regulate water transport in the IM remains to be
determined. A dual Ang II/AVP receptor sharing similar
transmembrane and binding domains, Gs protein-activation
motifs and endocytosis-promoting sequences has been pro-
posed,29 but it has not been confirmed by others. Klingler
et al.30 showed that Ang II potentiated AVP-dependent cAMP
accumulation in CHO cells cotransfected with AT1a and V2
receptors. In NaCl-restricted rats, Kwon et al.31 showed that
blockade of AT1 receptor signaling with candesartan was
associated with decreased urine concentration and AQP2
expression during 1-desamino-8-D-arginine vasopressin infu-
sion. Kwon’s group further showed that in primary cultured
inner medullary collecting duct cells, Ang II and 1-desamino-
8-D-arginine vasopressin both increased phosphorylation of
AQP2 proteins and trafficking of AQP2 proteins to the cell
membranes.28 Thus, our results are consistent with above-
mentioned studies, and confirm that AT1a receptor signaling is
necessary for AVP-induced expression of membrane AQP2,
AC-III, and AC-V/VI, and regulation of urine concentration.
MATERIALS AND METHODS
Animals
A total of 10 groups of wild-type (C57BL/6J) and AT1a-KO mice
(Agtr1a/) were used in this study (n¼ 6 to 12 per group, unless
specified elsewhere). AT1a-KO mice were genotyped before the
experiment and confirmed at the end of studies for the lack of AT1
receptor binding in the kidney.15,16
Inner medullary structures in WT and AT1a-KO mice
Frozen sections (6mm) of WT and AT1a-KO kidneys were stained
with hematoxylin and eosin for microscopic visualization. Total
inner medullary proteins in WT and AT1a-KO mice were measured
and normalized to the kidney weight for comparisons.
Effects of [Arg8]-AVP on urine concentration in
WT and AT1a-KO mice
To determine the role of partial central diabetes insipidus in the
development of urine concentrating defects in AT1a-KO mice, an
osmotic minipump (Model 2002, Alza Corp., Mountain View, CA,
USA) was implanted intraperitoneally in WT and AT1a-KO mice for
infusion of [Arg8]-AVP for 2 weeks (100 ng/h).7,15,16,32 Control WT
and AT1a-KO mice were not treated with [Arg
8]-AVP. Furthermore,
one group of WT and AT1a-KO mice were deprived of water for 16 h
before they were treated with exogenous [Arg8]-AVP (100 ng, intra-
peritoneally). Urine samples were collected by bladder massage over a
3-h period after AVP treatment for measurement of urine osmolality.
Effects of acute 24-h or chronic 5-day water ration on urine
concentration in WT and AT1a-KO mice
Two groups of WT and AT1a-KO mice were placed on a 24-h or
5-day water ration protocol, in which all mice had equal access to
4 ml water within a 24-h period.
Effects of administration of an osmotic agent on polyuria
and urine concentration in WT and AT1a-KO mice
Two groups of WT and AT1a-KO mice were treated with the osmotic
agent (10% sucrose, in drinking solution) acutely for 24 h or
chronically for 2 weeks.18
Measurement of plasma [Arg8]-AVP
At the end of experiment, mice were decapitated without anesthesia
and blood samples collected as described.6,21,22 Plasma [Arg8]-AVP was
measured using a sensitive ELISA kit (Bachem, Torrance, CA, USA).
Measurement of plasma and urine osmolality
At the end of experiment, mice were decapitated without anesthesia
and blood and urine samples collected for measurements of plasma
and urine osmolality using an osmometer.4,6
Measurement of GFR
To determine whether polyuria and urine concentrating defects was
because of markedly increased GFR in AT1a-KO mice, one group
of WT and AT1a-KO mice were infused with 3% fluorescein
isothiocyanate-labeled inulin (Sigma, St Louis, MO, USA) through
an osmotic minipump for 2 weeks.13 Blood samples were collected
from tail vessels weekly or by decapitation at the end of experiment,
whereas 24-h urine samples were collected using metabolic cages.
Plasma and urine concentrations of fluorescein isothiocyanate-
labeled inulin were measured by a fluorescence plate reader.
[125I]-V2 receptor binding in the IM
Vasopressin V2 receptor binding in the kidney was visualized and
quantitated using in vitro autoradiography of [125I]-V2R analog.
23
Western blot analysis of lysate and membrane AQP2 proteins
Lysate and membrane AQP2 proteins were measured by western
blot using a goat polyclonal antibody targeting the C-terminus
of AQP2 of human origin (sc-9882; Santa Cruz, Santa Cruz, CA,
USA; 1:200).28,31,33,34 Signals were detected using enhanced chemilu-
minescence (Amersham, Piscataway, NJ, USA), as described.35–37
Western blot analysis of AC-III and AC-V/VI proteins
The AC-III and AC-V/VI proteins in the IM of WT and AT1a-KO
mice were measured by western blot using a rabbit antibody
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targeting the C-terminus of AC-III of mouse origin (sc-588; Santa
Cruz; 1:200) or a rabbit antibody targeting the C-terminus of AC-V/
VI of human origin (sc-590; Santa Cruz; 1:200).25,26
Western blot analysis of total and phosphorylated MAP
kinases ERK 1/2
Total (t-ERK 1/2) and p-ERK 1/2 in the IM of WT and AT1a-KO
mice were determined as described.35–37
Statistical analysis
Data are presented as means±s.e. of groups of 6–12 WT and
AT1a-KO mice. One-way ANOVA (analysis of variance) was used to
compare the differences between basal and after treatments in the
same strain of mice, whereas unpaired Student’s t-test was used to
compare the differences in the same parameters between WT and
AT1a-KO mice before or after a treatment. The significance was set
at Po0.05.
DISCLOSURE
This study was supported in part by a grant from the National
Institute of Diabetes, Digestive and Kidney Diseases (5RO1DK067299)
and an institutional grant from Henry Ford Health System (A10216)
to Dr Zhuo.
ACKNOWLEDGMENTS
Portions of the results in this work were presented at Renal Week
2007, American Society of Nephrology, in San Francisco, California,
October 31–November 5, 2007, and published as an abstract in
J Am Soc Nephrol 2007; 18: 66A.
REFERENCES
1. Kim HS, Krege JH, Kluckman KD et al. Genetic control of blood pressure and
the angiotensinogen locus. Proc Natl Acad Sci USA 1995; 92: 2735–2739.
2. Kihara M, Umemura S, Sumida Y et al. Genetic deficiency of
angiotensinogen produces an impaired urine concentrating ability in
mice. Kidney Int 1998; 53: 548–555.
3. Esther CR, Marino EM, Howard TE et al. The critical role of tissue
angiotensin-converting enzyme as revealed by gene targeting in mice.
J Clin Invest 1997; 99: 2375–2385.
4. Oliverio MI, Kim HS, Ito M et al. Reduced growth, abnormal kidney
structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure
regulation in mice lacking both AT1a and AT1b receptors for angiotensin
II. Proc Natl Acad Sci USA 1998; 95: 15496–15501.
5. Ito M, Oliverio MI, Mannon PJ et al. Regulation of blood pressure by the type
1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995; 92: 3521–3525.
6. Oliverio MI, Delnomdedieu M, Best CF et al. Abnormal water metabolism
in mice lacking the type 1A receptor for ANG II. Am J Physiol Renal Physiol
2000; 278: F75–F82.
7. Robertson GL. Regulation of vasopressin secretion. In: Seldin DW,
Giebisch G (eds). The Kidney: Physiology and Pathophysiology, 2nd edn,
Raven Press: New York, 1992, pp 1595–1613.
8. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev 1998;
78: 583–686.
9. Carmosino M, Brooks HL, Cai Q et al. Axial heterogeneity of vasopressin-
receptor subtypes along the human and mouse collecting duct. Am J
Physiol Renal Physiol 2007; 292: F351–F360.
10. Ecelbarger CA, Chou CL, Lolait SJ et al. Evidence for dual signaling
pathways for V2 vasopressin receptor in rat inner medullary collecting
duct. Am J Physiol 1996; 270: F623–F633.
11. Yip KP. Coupling of vasopressin-induced intracellular Ca2+ mobilization
and apical exocytosis in perfused rat kidney collecting duct. J Physiol
2002; 538: 891–899.
12. Nielsen S, Frokiaer J, Marples D et al. Aquaporins in the kidney: from
molecules to medicine. Physiol Rev 2002; 82: 205–244.
13. Qi Z, Whitt I, Mehta A et al. Serial determination of glomerular filtration
rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal
Physiol 2004; 286: F590–F596.
14. Chen X, Li W, Yoshida H et al. Targeting deletion of angiotensin type 1B
receptor gene in the mouse. Am J Physiol 1997; 272: F299–F304.
15. Li XC, Navar LG, Shao Y et al. Genetic deletion of AT1a receptors
attenuates intracellular accumulation of angiotensin II in the kidney of
AT1a receptor-deficient mice. Am J Physiol Renal Physiol 2007; 293:
F586–F593.
16. Li XC, Zhuo JL. In vivo regulation of AT1a receptor-mediated intracellular
uptake of [125I]-Val5-angiotensin II in the kidneys and adrenal glands of
AT1a receptor-deficient mice. Am J Physiol Renal Physiol 2008; 294:
F293–F302.
17. Liu G, Daneshgari F. Temporal diabetes- and diuresis-induced remodeling
of the urinary bladder in the rat. Am J Physiol Regul Integr Comp Physiol
2006; 291: R837–R843.
18. Kim D, Sands JM, Klein JD. Changes in renal medullary transport proteins
during uncontrolled diabetes mellitus in rats. Am J Physiol Renal Physiol
2003; 285: F303–F309.
19. Kim D, Sands JM, Klein JD. Role of vasopressin in diabetes
mellitus-induced changes in medullary transport proteins involved in
urine concentration in Brattleboro rats. Am J Physiol Renal Physiol 2004;
286: F760–F766.
20. de Gasparo M, Catt KJ, Inagami T et al. International union of
pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev
2000; 52: 415–472.
21. Morris M, Means S, Oliverio MI et al. Enhanced central response to
dehydration in mice lacking angiotensin AT1a receptors. Am J Physiol
Regul Integr Comp Physiol 2001; 280: R1177–R1184.
22. Morris M, Li P, Callahan MF et al. Neuroendocrine effects of dehydration in
mice lacking the angiotensin AT1a receptor. Hypertension 1999; 33: 482–486.
23. Tian Y, Sandberg K, Murase T et al. Vasopressin V2 receptor binding is
down-regulated during renal escape from vasopressin-induced
antidiuresis. Endocrinology 2000; 141: 307–314.
24. Terashima Y, Kondo K, Mizuno Y et al. Influence of acute elevation of
plasma AVP level on rat vasopressin V2 receptor and aquaporin-2 mRNA
expression. J Mol Endocrinol 1998; 20: 281–285.
25. Bek MJ, Zheng S, Xu J et al. Differential expression of adenylyl cyclases in
the rat nephron. Kidney Int 2001; 60: 890–899.
26. Hoffert JD, Chou CL, Fenton RA et al. Calmodulin is required for
vasopressin-stimulated increase in cyclic AMP production in inner
medullary collecting duct. J Biol Chem 2005; 280: 13624–13630.
27. Hasler U, Numes P, Bouley R et al. Acute hypotonicity alters aquaporin-2
trafficking and induces a MAP-kinase-dependent accumulation at the
plasma membrane of renal epithelial cells. J Biol Chem 2008; 283:
26643–26661.
28. Lee YJ, Song IK, Jang KJ et al. Increased AQP2 targeting in primary
cultured IMCD cells in response to angiotensin II through AT1 receptor.
Am J Physiol Renal Physiol 2007; 292: F340–F350.
29. Ruiz-Opazo N, Akimoto K, Herrera VL. Identification of a novel dual
angiotensin II/vasopressin receptor on the basis of molecular recognition
theory. Nat Med 1995; 1: 1074–1081.
30. Klingler C, Ancellin N, Barrault MB et al. Angiotensin II potentiates
vasopressin-dependent cAMP accumulation in CHO transfected cells.
Mechanisms of cross-talk between AT1A and V2 receptors. Cell Signal
1998; 10: 65–74.
31. Kwon TH, Nielsen J, Knepper MA et al. Angiotensin II AT1 receptor
blockade decreases vasopressin-induced water reabsorption and AQP2
levels in NaCl-restricted rats. Am J Physiol Renal Physiol 2005; 288:
F673–F684.
32. Brooks HL, Ageloff S, Kwon TH et al. cDNA array identification of genes
regulated in rat renal medulla in response to vasopressin infusion. Am J
Physiol Renal Physiol 2003; 284: F218–F228.
33. Hasler U, Mordasini D, Bens M et al. Long term regulation of aquaporin-2
expression in vasopressin-responsive renal collecting duct principal cells.
J Biol Chem 2002; 277: 10379–10386.
34. Chou CL, Yip KP, Michea L et al. Regulation of aquaporin-2 trafficking by
vasopressin in the renal collecting duct. Roles of ryanodine-sensitive
Ca2+ stores and calmodulin. J Biol Chem 2000; 275: 36839–36846.
35. Li XC, Zhuo JL. Selective knockdown of AT1 receptors by RNA interference
inhibits Val5-Ang II endocytosis and NHE-3 expression in immortalized
rabbit proximal tubule cells. Am J Physiol Cell Physiol 2008; 293:
C367–C378.
36. Li XC, Carretero OA, Shao Y et al. Glucagon receptor-mediated
extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial
cells: role of protein kinase A and phospholipase C. Hypertension 2006;
47: 580–585.
37. Li XC, Carretero OA, Zhuo JL. Cross-talk between angiotensin II
and glucagon receptor signaling mediates phosphorylation of
mitogen-activated protein kinase ERK1/2 in rat glomerular mesangial
cells. Biochem Pharmacol 2006; 71: 1711–1719.
Kidney International (2009) 76, 169–177 177
XC Li et al.: AT1a receptor knockout and water metabolism o r i g i n a l a r t i c l e
